These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 22201977)

  • 21. How does brain insulin resistance develop in Alzheimer's disease?
    De Felice FG; Lourenco MV; Ferreira ST
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S26-32. PubMed ID: 24529521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin mediated novel therapies for the treatment of Alzheimer's disease.
    Dubey SK; Lakshmi KK; Krishna KV; Agrawal M; Singhvi G; Saha RN; Saraf S; Saraf S; Shukla R; Alexander A
    Life Sci; 2020 May; 249():117540. PubMed ID: 32165212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alzheimer's disease and diabetes - the common pathogenesis].
    Halmos T; Suba I
    Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
    Heininger K
    Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.
    de la Monte SM; Tong M; Lester-Coll N; Plater M; Wands JR
    J Alzheimers Dis; 2006 Sep; 10(1):89-109. PubMed ID: 16988486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
    Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling.
    Rhein V; Eckert A
    Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance and Alzheimer's disease.
    de la Monte SM
    BMB Rep; 2009 Aug; 42(8):475-81. PubMed ID: 19712582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance, neuroinflammation, and Alzheimer's disease.
    Najem D; Bamji-Mirza M; Chang N; Liu QY; Zhang W
    Rev Neurosci; 2014; 25(4):509-25. PubMed ID: 24622783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms linking brain insulin resistance to Alzheimer's disease.
    Matioli MNPS; Nitrini R
    Dement Neuropsychol; 2015; 9(2):96-102. PubMed ID: 29213950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed.
    de la Monte SM
    J Alzheimers Dis; 2012; 30 Suppl 2(0 2):S231-49. PubMed ID: 22337830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease and insulin resistance: translating basic science into clinical applications.
    De Felice FG
    J Clin Invest; 2013 Feb; 123(2):531-9. PubMed ID: 23485579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
    Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R
    Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.
    Morgen K; Frölich L
    J Neural Transm (Vienna); 2015 Apr; 122(4):499-504. PubMed ID: 25673434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
    Lester-Coll N; Rivera EJ; Soscia SJ; Doiron K; Wands JR; de la Monte SM
    J Alzheimers Dis; 2006 Mar; 9(1):13-33. PubMed ID: 16627931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.
    Ali T; Rehman SU; Khan A; Badshah H; Abid NB; Kim MW; Jo MH; Chung SS; Lee HG; Rutten BPF; Kim MO
    Mol Neurodegener; 2021 Apr; 16(1):23. PubMed ID: 33849621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.